VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1653228
Sex: F
Age:
State: TN

Vax Date: 07/07/2021
Onset Date: 07/11/2021
Rec V Date: 08/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Dose 1 on 07Apr2021 and dose 2 on 07Jul2021; Body chills but hot to touch; Body chills but hot to touch; armpit swelling/neck swollen; This is a spontaneous report from a contactable consumer, the patient. A 29-years-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 07Jul2021 at 11:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no known allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 07Apr2021 at 10:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Jul2021 at 07:00, the patient experienced body chills but hot to touch, armpit swelling and neck swollen. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event body chills but hot to touch, armpit swelling and neck swollen were not recovered at the time of this report. The lot number for BNT162b2 was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1653229
Sex: U
Age:
State: WI

Vax Date: 07/11/2021
Onset Date: 07/11/2021
Rec V Date: 08/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210711; Test Name: temperature; Result Unstructured Data: Test Result:UNKNOWN RESULTS; Comments: at 12:00 PM

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Temperature; Sleepless night; This is a spontaneous report from a non-contactable consumer, the patient. An unspecified aged elderly patient of unknown gender received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0198) via an unspecified route of administration in the left arm on 11Jul2021 at 08:30 as a single dose for COVID-19 immunisation. Medical history included COVID-19 (Prior to the vaccination, the patient was diagnosed with COVID-19). The patient had known allergies to dust. Concomitant medications included apixaban (ELIQUIS) from an unknown date for unknown indication. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 11Jul2021 at 12:00, the patient experienced sleepless night and temperature. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcome of event sleepless night and temperature was recovering at the time of this report. No follow-up attempts are possible. No further information is expected

Other Meds: ELIQUIS

Current Illness:

ID: 1653230
Sex: F
Age:
State: NC

Vax Date: 06/22/2021
Onset Date: 06/23/2021
Rec V Date: 08/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Cold symptoms for 2-3 weeks; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 22Jun2021 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient was not allergic to medications, food, or other products. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included bupropion hydrochloride (WELLBUTRIN) and fluoxetine hydrochloride (PROZAC). The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01Jun2021 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. On 23Jun2021, the patient experienced cold symptoms for 2-3 weeks. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event cold symptoms was resolving at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: WELLBUTRIN; PROZAC

Current Illness:

ID: 1653231
Sex: F
Age:
State: NC

Vax Date: 06/15/2021
Onset Date: 06/18/2021
Rec V Date: 08/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data: Test Date: 20210618; Test Name: Blood glucose; Result Unstructured Data: Test Result:Increased; Comments: High blood sugar

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: High blood sugar; Dry eyes; Blur vision; This is a spontaneous report from a contactable consumer, the patient. A 69-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO179) via an unspecified route of administration in the left arm on 15Jun2021 at 10:00(at the age of 69-year-old) as a single dose for COVID-19 immunisation. Medical history included type 2 diabetes mellitus, blood pressure high, chronic pain and legally blind. The patient did not receive any concomitant medications. The patient had unspecified known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Jun2021 at 04:00, the patient experienced blur vision and could have needed a new transplant in left eye, was waiting for follow up visit appointment soon. The patient also experienced high blood sugar, was waiting on call back from doctor and dry eyes. On 18Jun2021, the patient underwent blood glucose test and the result was blood sugar increased. Therapeutic measures were not taken as a result of adverse events. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events blur vision, high blood sugar and dry eye was unknown at the time of this report.

Other Meds:

Current Illness:

ID: 1653232
Sex: F
Age:
State: CA

Vax Date: 02/26/2021
Onset Date: 06/05/2021
Rec V Date: 08/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: CT Scan; Result Unstructured Data: Test Result:unspecified results; Test Name: Magnetic resonance imaging; Result Unstructured Data: Test Result:unspecified results

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Migraines; Eyesight since migraine gotten blurry; This is a spontaneous report received from a contactable consumer (patient) via COVID-19 adverse event self-reporting method. A 47-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201) via an unspecified route of administration in the arm right on 26Feb2021 at 15:00 (at the age of 47-year-old) as a single dose for COVID-19 immunisation and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the arm right on an unknown date in 2021 as a single dose for COVID-19 immunisation. Medical history included migraine from an unknown date and the patient stated that she had migraines her whole life. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had received unspecified concomitant medications. The patient experienced migraines and eyesight since migraine gotten blurry from 05Jun2021 at 08:00. Details were as follows: on 05Jun2021 at 08:00, she started with migraines and had continued daily pounding to, at the time of this report (12Jul2021) and her eyesight since migraine gotten blurry. On an unknown date, the patient had an MRI (magnetic resonance imaging), CT (computed tomography) scan (results unspecified). She had been to the neurologist, pain doctor, chiropractor, holistic doctor, eye doctor (because her eyesight since this migraine had gotten blurry) and they could not find anything. The patient explained that no medication would help her with the pain which was odd, as when she normally would get a migraine, something would help. The patient stated, nothing had helped. The only change in her life had been the vaccine. The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of these events. Since the vaccination, the patient has not been tested for COVID-19. The clinical outcome of migraines and eyesight since migraine gotten blurry was not recovered.

Other Meds:

Current Illness:

ID: 1653233
Sex: F
Age:
State: CA

Vax Date: 04/22/2021
Onset Date: 04/29/2021
Rec V Date: 08/29/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Knee joint pain. Started about a week after my second shot and has gotten progressively worse.; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 22Apr2021 at 17:00 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma and depression. The patient has known allergy to penicillin (reported as possible penicillan). Concomitant medications included acetylsalicylic acid (BABY ASPIRIN), fluticasone propionate, salmeterol xinafoate (ADVAIR), lamotrigine (LAMICTAL), salbutamol (VENTOLIN) and fluoxetine hydrochloride (PROZAC) all for unknown indication from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 01Apr2021 at 17:00 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Apr2021 at 17:00 the patient experienced knee joint pain which started about a week after the second shot and has gotten progressively worse. Therapeutic measures were not taken as a result of the event. The event did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event knee joint pain which started about a week after the second shot and has gotten progressively worse was not recovered at the time of this report.

Other Meds: BABY ASPIRIN; ADVAIR; LAMICTAL; VENTOLIN [SALBUTAMOL]; PROZAC

Current Illness:

ID: 1653234
Sex: F
Age:
State: TX

Vax Date: 06/01/2021
Onset Date: 06/05/2021
Rec V Date: 08/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210507; Test Name: SARS-CoV2-test; Test Result: Negative ; Comments: Nasal swab

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: A few days after the vaccine, I woke up dizzy. Dizziness hasn't stopped since then and it has been over a month.; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169), via an unspecified route of administration on 01Jun2021 (at the age of 28-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. It was unknown whether the patient receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration on 29Apr2021 (at the age of 28-years-old), as a single dose for COVID-19 immunisation. On 05Jun2021, the patient experienced "a few days after the vaccine, I woke up dizzy. Dizziness hasn't stopped since then and it has been over a month". The event resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of event which included treatment for vertigo but it did not solve. On 07May2021, the patient underwent SARS-CoV-2 test (nasal swab) and the result was negative. The clinical outcome of the event "a few days after the vaccine, I woke up dizzy. Dizziness hasn't stopped since then and it has been over a month" was not resolved at the time of reporting.

Other Meds:

Current Illness:

ID: 1653235
Sex: F
Age:
State: IA

Vax Date: 04/29/2021
Onset Date: 07/05/2021
Rec V Date: 08/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: COVID-19 test; Test Result: Negative ; Comments: Nasal swab

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Shingles on my cornea on my right eye - vision impaired; Shingles on my cornea on my right eye - vision impaired; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176) via an unspecified route of administration in the left arm on 29Apr2021 at 14:15 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had no known allergies to medications, food, or other products. The patient did not receive any medication within two weeks of vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the right arm on 08Apr2021 at 14:00 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Jul2021, the patient experienced shingles on her cornea on her right eye - vision impaired. The events resulted in doctor or other healthcare professional office/clinic visit. The events resulted in emergency room/department visit or urgent care. Therapeutic measures were taken as a result of shingles on her cornea on her right eye - vision impaired and included treatment with Eye drops and oral medication. Since the vaccination, the patient had been tested for COVID-19. On an unknown date, the patient underwent COVID-19 test via nasal swab and the result was negative. The clinical outcome of the events shingles on her cornea on her right eye - vision impaired was not resolved at the time of this report.

Other Meds:

Current Illness:

ID: 1653236
Sex: F
Age:
State: VA

Vax Date: 03/09/2021
Onset Date: 04/28/2021
Rec V Date: 08/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 2021; Test Name: CT scan; Result Unstructured Data: Test Result:Unknown results

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: upper abdominal pain; consistent vomiting and nausea; consistent vomiting and nausea; This is a spontaneous report from a contactable consumer (patient) received via COVID-19 Vaccine Reporting System. A 52-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 (also reported as dose 2) via an unspecified route of administration, administered in arm left on 09Mar2021 (at the age of 52-years; Lot Number: EN6206) (also reported as: ER8727) as DOSE 1, SINGLE for COVID-19 immunisation. Medical history included alpha 1 antitrypsin deficiency and psoriasis. Concomitant medications included adalimumab (HUMIRA); escitalopram oxalate (LEXAPRO). The patient previously took cefalexin monohydrate (KEFLEX) and experienced drug allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not pregnant at the time of vaccination. On 28Apr2021 08:00, the patient experienced sudden onset of upper abdominal pain followed by consistent vomiting and nausea for 5 days. The second episode with exact same symptoms occurred approximately 2 months after the vaccine was administered. The events resulted in emergency room/department or urgent care. Therapeutic measures were taken as the result of the events which included IV (unspecified, for clarification), Zofran, CT scan (unknown results). The outcome of the events was recovered on an unspecified date. Follow-up attempts are completed. No further information is expected.

Other Meds: HUMIRA; LEXAPRO

Current Illness:

ID: 1653237
Sex: F
Age:
State: CA

Vax Date: 07/02/2021
Onset Date: 07/05/2021
Rec V Date: 08/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: The swelling then spread to the leftside of my face and lips.; Two days after my second vaccine Ihad intense swelling under my left eye.The swelling then spread to the left side of my face and lips.There is still swelling under my left eye , to the left side of my nose, lowereye and upper left eyelid.Its painful; Had intense swelling under my left eye. The swelling then spread to the left side of my face and lips. There is still swelling under my left eye , to the left side of my nose, lower eye and upper left eyelid.Its painful.; The swelling then spread to the leftside of my face and lips.; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 02Jul2021 at 15:00 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. The patient had not reported any other health issue. The patient did not have any allergies to food, medications, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 18Jun2021 at 13:00 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. On 05Jul2021 at 04:45, two days after second vaccine, the patient had intense swelling under left eye, the swelling then spread to the left side of face and lips, there was still swelling under left eye, to the left side of nose, lower eye and upper left eyelid and it was painful. The event resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the patient had intense swelling under left eye, the swelling then spread to the left side of face and lips, there was still swelling under left eye, to the left side of nose, lower eye and upper left eyelid and it was painful which included treatment with Benadryl and prednisone. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events intense swelling under left eye, the swelling then spread to the left side of face and lips, there was still swelling under left eye, to the left side of nose, lower eye and upper left eyelid and it was painful was not recovered at the time of this report. The lot number for BNT162b2 was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1653238
Sex: F
Age:
State: NJ

Vax Date: 03/29/2021
Onset Date: 04/26/2021
Rec V Date: 08/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 20210711; Test Name: SARS-CoV-2 test; Test Result: Negative ; Comments: Nasal swab

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Bloating; Nausea; Mucus in stool; Abdominal issues since the vaccine; This is a spontaneous report from a contactable consumer, the patient. A 19-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734), via an unspecified route of administration in the left arm on 29Mar2021 at 15:45 (at the age of 19-years-old), as a single dose for COVID-19 immunisation. Medical history included nephrotic syndrome (remission), allergy to tree nuts and liquid latex allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient received unspecified birth control medication within two weeks of vaccination. On 26Apr2021, the patient experienced abdominal issues since the vaccine, bloating, nausea and mucus in stool. The events resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether any therapeutic measures were taken as a result of the events. On 11Jul2021, the patient underwent SARS-CoV-2 test and the result was negative. The clinical outcome of the events abdominal issues since the vaccine, bloating, nausea and mucus in stool were not resolved at the time of this report.

Other Meds:

Current Illness:

ID: 1653239
Sex: F
Age:
State: FL

Vax Date: 05/05/2021
Onset Date: 05/25/2021
Rec V Date: 08/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Large hard swollen lymph nodes in neck primarily on the left side; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the left arm on 05May2021 at 16:30 (at the age of 53-year-old) as a single dose for COVID-19 immunisation. The medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included metoprolol (MANUFACTURER UNKNOWN), spironolactone (SPIROLACTON) and valaciclovir hydrochloride (VALTREX). The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 07Apr2021 at 10:00 (at the age of 53-year-old) as a single dose for COVID-19 immunisation. On 25May2021, the patient experienced large hard swollen lymph nodes in neck primarily on the left side .The event resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event swollen lymph nodes was unknown at the time of this report.

Other Meds: METOPROLOL; SPIROLACTON; VALTREX

Current Illness:

ID: 1653240
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: tingling all throughout body after vaccination of first dose.; started having muscle spasms after receiving shot, , some are bigger spasms and others are smaller. but happening quiet constantly. still having spasms24 hours after vaccination.; This is a spontaneous report from a non-contactable consumer, the patient. A 20-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in 2021 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. Medical history included fruit allergy (bananas, avocados, apples), allergic to cats, adhesive tape allergy (some type of adhesive). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications were not reported. On an unknown date in 2021, the patient experienced tingling all throughout body after vaccination of first dose, started having muscle spasms after receiving shot, some were bigger spasms and others were smaller. But happened quiet constantly, still had spasms 24 hours after vaccination. The patient did not receive any treatment for the events. The clinical outcome of the events tingling all throughout body, muscle spasms after receiving shot, some were bigger spasms and others were smaller. But happened quiet constantly was not recovered at the of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness: Adhesive tape allergy (known allergies to some type of adhesive); Allergic to cats (known allergies to cats); Fruit allergy (Known allergies to bananas, avocados, apples.)

ID: 1653241
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: had a rash all over; This is a spontaneous report from a non-contactable consumer. A non-pregnant female patient of an unspecified age received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration on an unknown date, as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, it was unknown if the patient was diagnosed with COVID-19. It was unknown if the patient had received any other vaccines within 4 weeks prior to the COVID vaccine. On an unknown date, the patient had a rash all over. It was unknown if therapeutic measures were taken as a result of the event. Since the vaccination, it was unknown if the patient had been tested for COVID-19. The clinical outcome of the event, rash all over was unknown at the time of report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1653242
Sex: M
Age:
State: SC

Vax Date: 06/18/2021
Onset Date: 06/21/2021
Rec V Date: 08/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Dark rash multiple places on chest and arms; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0181) via an unspecified route of administration on 18Jun2021(at the age of 48-year-old) as a single dose for COVID-19 immunisation and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Jul2021 at 16:00 (at the age of 48-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not take any concomitant medication. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21Jun2021, the patient experienced dark rash multiple places on chest and arms. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event dark rash multiple places on chest and arms was not recovered at the time this report.

Other Meds:

Current Illness:

ID: 1653243
Sex: F
Age:
State: CA

Vax Date: 07/10/2021
Onset Date: 07/10/2021
Rec V Date: 08/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Worst headache; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the right arm on 10Jul2021 at 16:30 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included spironolactone (MANUFACTURER UNKNOWN) from unknown date for unknown indication. The patient had no allergies to medications, food, or other products. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0196), via an unspecified route of administration in the right arm on 19Jun2021 at 04:30 (at the age of 38-years-old), as a single dose for COVID-19 immunisation. On 10Jul2021 at 17:30, the patient experienced worst headache she had in life, at the base of her head and behind her forehead. It was accompanied by nausea and had been consistent for 3 days. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events worst headache and nausea were not resolved at the time of this report.

Other Meds: SPIRONOLACTONE

Current Illness:

ID: 1653244
Sex: F
Age:
State: MD

Vax Date: 06/12/2021
Onset Date: 06/13/2021
Rec V Date: 08/29/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Left eye twitching; Left eye vision problems; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: QW0177) via an unspecified route of administration in the left arm on 12Jun2021 at 10:00 (at the age of 53-year-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0217) via an unspecified route of administration in the left arm on 06Jul2021 (at the age of 53-year-old) as a single dose for COVID-19 immunisation. Medical history included psoriatic arthritis, blood pressure high (high BP), depression, anxiety and neuropathy. The patient received unspecified concomitant medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took methotrexate (MANUFACTURER UNKNOWN) for psoriatic arthritis (discontinued for 2 weeks after both doses), INDERAL LA and hydralazine (MANUFACTURER UNKNOWN) for blood pressure high (high BP), WELLBUTRIN and ABILIFY for depression and anxiety, gabapentin (MANUFACTURER UNKNOWN) for neuropathy all were taken from unknown dates and unknown if ongoing. On 13Jun2021 at 12:00, the patient experienced left eye twitching and left eye vision problems after receiving first and second dose, problem went after two weeks on first dose, still experiencing symptoms since receiving second dose on 06Jul2021(as reported). The adverse events did not result in doctor or other healthcare professional office/clinic visit/emergency visit. Therapeutic measures were not taken as a result of these events. The clinical outcome of the events left eye twitching and left eye vision problems was recovering at the time of this report.

Other Meds:

Current Illness:

ID: 1653245
Sex: F
Age:
State: MN

Vax Date: 04/24/2021
Onset Date: 04/30/2021
Rec V Date: 08/29/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data: Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Heart aches and pains; shortness of breath; This is a spontaneous report from a contactable consumer (patient). A 43-year-old non-pregnant female patient received bnt162b2 (BNT162B2 reported as PFIZER COVID VACCINE), dose 1 at vaccination age of 43-year-old via an unspecified route of administration in the left arm on 24Apr2021 13:00 (Batch/Lot number was not reported) as dose 1, single for covid-19 immunisation. Medical history included heart disease family history. The patient was not diagnosed with covid prior vaccination. The patient has no known allergies. There were no concomitant medications. The patient received the vaccine in a public health clinic. The patient did not receive other vaccine in four weeks. On 30Apr2021, the patient had heart aches and pains, and shortness of breath started within 2 weeks after her first dose at a public facility. The patient did not received treatment for the adverse event. The patient had a nasal swab on an unspecified date with negative results. The outcome of the events was unknown. The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1653246
Sex: M
Age:
State: VA

Vax Date: 06/02/2021
Onset Date: 06/02/2021
Rec V Date: 08/29/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Instant and massive IBS attack 30 seconds after injection; Bloating; discomfort and pain from gas pressure in stomach; discomfort and pain from gas pressure in stomach; Weakness is constant in left arm at injection point.; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8735) via an unspecified route of administration in the left arm on 02Jun2021 at 10:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history included GERD, irritable bowel syndrome (IBS) and cholinergic urticaria. The patient was allergic to sulfa drugs. Concomitant medications included famotidine (PEPCID), fexofenadine hydrochloride (ALLEGRA) and mentha x piperita oil (IBGARD); all taken for unknown indications from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0157) via an unspecified route of administration in the left arm on 13May2021 at 09:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Jun2021 at 10:00, the patient experienced instant and massive IBS attack 30 seconds after injection, bloating, discomfort and pain from gas pressure in stomach. All over the counter remedies had failed and weakness was constant in left arm at injection point. Daily and constant IBS attacks 24 hours a day, 7 days a week, previously attacks used to be every other week, or after misbehaving. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events which included treatment with unspecified medications and had a referral to a gastro specialist. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event instant and massive IBS attack 30 seconds after injection, bloating, discomfort and pain from gas pressure in stomach and weakness was constant in left arm at injection point were not recovered at the time of this report.

Other Meds: PEPCID [FAMOTIDINE]; ALLEGRA; IBGARD

Current Illness:

ID: 1653247
Sex: F
Age:
State: CO

Vax Date: 07/08/2021
Onset Date: 07/10/2021
Rec V Date: 08/29/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: A rash about 3 x 3 and rounded below right shoulder looks like shingles but does not hurt or itch; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Jul2021 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. Medical history included autism. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Jul2021, the patient experienced a rash about 3 x 3 and rounded below right shoulder which looked like shingles but did not hurt or itch. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events a rash about 3 x 3 and rounded below right shoulder looks like shingles but does not hurt or itch were not resolved at the time of this report. The lot number for BNT162b2 was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1653248
Sex: M
Age:
State: CA

Vax Date: 02/23/2021
Onset Date: 02/27/2021
Rec V Date: 08/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Major loss of smell; Major loss of taste; This is a spontaneous report from a contactable consumer, the patient. A 76-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 23Feb2021(at the age of 76-years-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included simvastatin (MANUFACTURER UNKNOWN) and lisinopril (MANUFACTURER UNKNOWN); both from an unknown date for unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6200) via an unspecified route of administration in the left arm on an unknown date in 2021 at 02:00 as a single dose for COVID-19 immunisation. It was reported that the patient had no allergies to medications, food, or other products. On 27Feb2021 after 4 days, the patient experienced major loss of smell and taste. The patient had no improvement for the events till 12Jul2021. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events loss of smell and taste was not recovered at the time of this report.

Other Meds: SIMVASTATIN; LISINOPRIL

Current Illness:

ID: 1653249
Sex: F
Age:
State: CA

Vax Date: 03/03/2021
Onset Date: 03/03/2021
Rec V Date: 08/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Got a metallic taste in the mouth; Flush; Felt sick; Muscle cramping; Severe fatigue; Aching; Not been able to walk more than a few blocks or exercise since; Flu-like symptoms; Not been able to walk more than a few blocks or exercise/muscles go into cramps doing small things like stairs or an incline on the street or even just house cleaning getting up and down; Get out of breath; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the right arm on 03Mar2021 at 10:00 (at the age of 52-year-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration on 24Mar2021 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. Medical history included drug allergy to cephalosporin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. It was reported that the patient was in good health while receiving both the first and second doses of the vaccine. The patient was walking and jogging 6 miles a day. The minute the patient received the vaccines, she got a metallic taste in the mouth, flush and then felt sick for an hour. This went away both the times, however, the patient had muscle cramping and severe fatigue and aching since the first dose and had not been able to walk more than a few blocks or exercise since. It had now been 3.5 months of waiting for the flu-like symptoms to go away. The patient's muscles went into cramps doing small things like stairs or an incline on the street or even just house cleaning while getting up and down and the patient got out of breath. The patient had been to the doctor and could not find the cause. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events metallic taste, flush and felt sick were resolved on an unknown date in 2021. The clinical outcome of the events muscle cramping, severe fatigue, aching, and not been able to walk more than a few blocks or exercise since, flu-like symptoms, muscles go into cramps doing small things like stairs or an incline on the street or even just house cleaning getting up and down and get out of breath were not resolved at the time of this report.

Other Meds:

Current Illness:

ID: 1653250
Sex: F
Age:
State: CA

Vax Date: 05/04/2021
Onset Date: 05/01/2021
Rec V Date: 08/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: last 3 fingers in right hand went numb/ numbness in hand; pain in lower neck; pain in shoulder area; tingling and numbness in hand.; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 04May2021 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant past medical history and no known allergies to medications, food or other products. Concomitant medication included tamoxifen (TAMOXIFENE); taken for unknown indication on unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05May2021, the day after the shot the patient experienced pain in lower neck and shoulder area and on 09May2021, 5 days later the last 3 fingers in right hand went numb. The pain was controlled with prescriptions, but later on an unknown date in May2021 pain returned and she had continued tingling and numbness in hand. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events which included unspecified prescription medicine. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome events pain in lower neck, pain in shoulder area, last 3 fingers in right hand went numb/ numbness in hand and tingling in fingers and hands was not recovered. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0187) via an unspecified route of administration in the left arm on 25May2021 as a single dose for COVID-19 immunisation.

Other Meds: TAMOXIFENE [TAMOXIFEN]

Current Illness:

ID: 1653251
Sex: F
Age:
State: IA

Vax Date: 03/03/2021
Onset Date: 03/15/2021
Rec V Date: 08/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Blisters on arm with shot, blisters on hip (same side), blisters on back; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 03Mar2021 at 09:00 (at the age of 65-year-old), as a single dose and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date in 2021 (at the age of 65-year-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any concomitant medications. On 15Mar2021 at 13:15, the patient experienced blisters on arm with shot, then blisters on the hip (same side), and then blisters on the back. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event which included treatment with corticoid cream (MANUFACTURER UNKNOWN). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event blisters on arm with shot, blisters on hip (same side), blisters on back was not recovered at the time of this report. The lot number for BNT162b2 was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1653252
Sex: F
Age:
State: TX

Vax Date: 03/19/2021
Onset Date: 03/19/2021
Rec V Date: 08/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: arm continues to be sore at the injection site and the surrounding area; Arm continues to be swollen at the injection site and the surrounding area; With some reduction in range of motion; Feeling tingling in feet, primarily left foot; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 19Mar2021 at 13:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had known allergies to gluten. The patient did not receive any concomitant medication. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 19Mar2021, the patient arm continued to sore and swollen at the injection site and the surrounding area, with some reduction in her range of motion. The patient also reported that she felt tingling on her feet, primarily patient left foot where patient have never had that before, It was not debilitating but very annoying and not getting better. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore, swollen at the injection site, the surrounding area with some reduction in range of motion and felt tingling on feet, primarily left foot were not recovered at the time of this report. The lot number for BNT162b2 was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1653253
Sex: M
Age:
State:

Vax Date: 02/01/2020
Onset Date: 02/01/2020
Rec V Date: 08/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Burning in both right and left feet; Tingling in both right,left feet and hands; Local burning sensation in thighs; Numbness in left little finger, 5th digit; This is a spontaneous report from a non contactable consumer, the patient. A 48-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: EL9269) via an unspecified route of administration on an unknown date in Feb2020 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On an unknown date in Feb2020 the patient experienced burning in both right and left feet, tingling in both right, left feet and hands, local burning sensation in thighs and numbness in left little finger. No therapeutic measures were taken as a result of reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events of burning in both right and left feet, tingling in both right, left feet and hands, local burning sensation in thighs and numbness in left little finger was unknown at the time of this report.

Other Meds:

Current Illness:

ID: 1653254
Sex: F
Age:
State: NJ

Vax Date: 07/06/2021
Onset Date: 07/06/2021
Rec V Date: 08/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Headache; This is a spontaneous report from a non-contactable other healthcare professional, the patient. A 48-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 06Jul2021 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included brain hemorrhage that has resolved. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Jul2021, on the day of vaccination, the patient experienced headache which did not go away. Therapeutic measures were taken as a result of headache and included treatment with unspecified medication started on an unknown date. The clinical outcome of the event headache was not resolved at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1653255
Sex: F
Age:
State: TX

Vax Date: 07/13/2021
Onset Date: 07/13/2021
Rec V Date: 08/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Hearing difference/difficulty; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 13Jul2021 at 13:15 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had allergies to medications, food, or other products which was unspecified. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included Multivitamins (MANUFACTURER UNKNOWN) from unknown date and for unspecified indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Jul2021 at 23:00 the patient experienced hearing difference/difficulty. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of adverse events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event hearing difference/difficulty was not resolved at the time of report. The lot number for BNT162b2 was not provided and will be requested during follow up

Other Meds:

Current Illness:

ID: 1653256
Sex: F
Age:
State: MI

Vax Date: 07/02/2021
Onset Date: 07/03/2021
Rec V Date: 08/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: muscle and joint pain in knees and legs and ankle; muscle and joint pain in knees and legs and ankle; I had a fever with 2nd dose within 18 hrs after shot; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0196) via an unspecified route of administration in the right arm on 02Jul2021 at 10:30 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history included type-2 diabetes mellitus which was borderline. The patient was allergic to latex and orange citric mixed with lemon. The patient did not receive any medication within 2 weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0217) via an unspecified route of administration in the right arm on 11Jun2021 at 11:00 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Jul2021 at 04:30, within 18 hours after the second dose, the patient experienced fever. On 09Jul2021, after 7 days of the second dose, the patient experienced muscle and joint pain in her knees, legs and ankle. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events and included treatment with Tylenol 500mg, twice in 24 hours. The clinical outcome of the events muscle and joint pain in knees, legs and ankle and fever were resolving at the time of this report.

Other Meds:

Current Illness:

ID: 1653257
Sex: F
Age:
State: FL

Vax Date: 05/19/2021
Onset Date: 05/19/2021
Rec V Date: 08/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: a large lump where the vaccine was administered; This is a spontaneous report from a non-contactable nurse, the patient. A 56-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0168) via intramuscular route of administration in the left arm on 19May2021 at 10:00 (at the age of 56-years-old). The patient did not have any relevant medical history. The patient had no known allergies to medications, food, or other products. The patient did not receive any concomitant medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19May2021 at 10:00, the patient had a large lump where the vaccine was administered and two months later the lump was still there. The patient had no pain or discomfort but a noted lump. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event a large lump where the vaccine was administered was not resolved at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1653258
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Tremors; Sharp shooting abdominal and intestinal pain; Sharp shooting abdominal and intestinal pain; Tingling; This is a spontaneous report from a non-contactable nurse, the patient. A 34-year-old female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On an unknown date, the patient experienced tremors, tingling sharp shooting abdominal and intestinal pain. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of events tremors, tingling Sharp shooting abdominal and intestinal pain was recovering at this time of report. No follow-up attempts are possible. No further information is expected

Other Meds:

Current Illness:

ID: 1653259
Sex: M
Age:
State: CT

Vax Date: 04/30/2021
Onset Date: 05/02/2021
Rec V Date: 08/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210612; Test Name: PCR test; Test Result: Negative ; Comments: Nasal swab

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: My left lymph node inflamed for about two weeks.; I got a flare up of psoriasis in my right knee; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 30Apr2021 at 18:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 08Apr2021 at 11:00 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. On 02May2021 at 06:00, during the following week the patient felt left lymph node inflamed for about two weeks. On an unknown date in 2021, about a week ago, the patient got a flare up of psoriasis in right knee and never had before. Since the vaccination, the patient had been tested for COVID-19. On 12Jun2021, the patient underwent lab test and procedure which included PCR test and the result was negative. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcome of event lymph node inflamed and flare up of psoriasis in right knee was not recovered at the time of this report.

Other Meds:

Current Illness:

ID: 1653260
Sex: F
Age:
State: GA

Vax Date: 07/01/2021
Onset Date: 07/05/2021
Rec V Date: 08/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: My initial side effects were relatively common. Such as injection site soreness, swelling for a few days following the vaccination.; My initial side effects were relatively common. Such as injection site soreness, swelling for a few days following the vaccination.; I have had incontrollable hunger, cravings.; I have had incontrollable hunger, cravings.; Since the vaccination I have gained 8lbs.; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on an unknown date in Jul2021 as a single dose for COVID-19 immunisation. Medical history included permanent sterilization (female sterilization), latex allergy and penicillin allergy. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Jul2021, the patient experienced initial side effects which were relatively common such as injection site soreness, swelling for a few days following the vaccination. 72 hours after the vaccination the patient had uncontrollable hunger, cravings. The patient was not pregnant. (Permanent sterilization). Since the vaccination the patient had gained 8 lbs. It was so severe that the patient thought that it should be reported. Perhaps other people were experiencing the same side effect. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event vaccination site soreness, swelling, uncontrollable hunger cravings and weight gain were unknown at the time of this report. The lot number for BNT162b2, were not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1653261
Sex: F
Age:
State: MS

Vax Date: 07/12/2021
Onset Date: 07/12/2021
Rec V Date: 08/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Today, the 14th, my tongue is no longer swollen but it's still a little numb. The rash is still present and my left side (of my waist) and back have started itching.; On the 13th the rash began to itch and more bumps formed around my navel. My appetite was gone and my tongue remained swollen and feeling funny.; On the 13th the rash began to itch and more bumps formed around my navel.; On the 13th the rash began to itch and more bumps formed around my navel. My appetite was gone and my tongue remained swollen and feeling funny.; On the 13th the rash began to itch and more bumps formed around my navel. My appetite was gone and my tongue remained swollen and feeling funny. I also felt fatigued all day.; On the evening of the 12th after the vaccine shot I noticed a rash on my stomach (left side). It didn't itch but there were around 8 bumps (different sizes). My tongue began to feel tingly and numb on top and became swollen and I had a little nausea; On the evening of the 12th after the vaccine shot I noticed a rash on my stomach (left side). It didn't itch but there were around 8 bumps (different sizes).; On the evening of the 12th after the vaccine shot I noticed a rash on my stomach (left side). It didn't itch but there were around 8 bumps (different sizes). My tongue began to feel tingly and numb on top and became swollen and I had a little nausea; On the evening of the 12th after the vaccine shot I noticed a rash on my stomach (left side). It didn't itch but there were around 8 bumps (different sizes). My tongue began to feel tingly and numb on top and became swollen and I had a little nausea; My tongue began to feel tingly and numb on top and became swollen and I had a little nausea. Today, the 14th, my tongue is no longer swollen but it's still a little numb; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FA6780) via an unspecified route of administration in the left arm on 12Jul2021 at 16:15 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included sickle cell trait (reported as No / sickle cell trait / None). The patient had latex allergy. The patient previously took bupropion (MANUFACTURER UNKNOWN) for unknown indication on unknown date and experienced drug allergy. Concomitant medications taken within two weeks of vaccination included fish oil pill (MANUFACTURER UNKNOWN), ascorbic acid (VITAMIN C) and multiple vitamin; all from unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On the evening of the 12Jul2021 at 22:00, after the vaccine shot the patient noticed a rash on her stomach (left side). It didn't itch but there were around eight bumps (different sizes). The patients tongue began to feel tingly and numb on top and became swollen and she had a little nausea. On the 13Jul2021 the rash began to itch and more bumps formed around her navel. The patients appetite was gone and her tongue remained swollen and feeling funny. She also felt fatigued all day. On 14Jul2021, the day of report, the patients tongue was no longer swollen but it was still a little numb. The rash was still present and her left side (of her waist) and back had started itching. Therapeutic measures were taken as a result of fatigue, itchy rash and itching and included treatment with two Tylenol since her shot and used benadryl cream for the itching. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events noticed a rash on her stomach (left side); it didn't itch but there were around eight bumps (different sizes) was not resolved at the time of this report. The clinical outcome of the events tongue began to feel tingly and numb on top was not resolved and of became swollen and remained swollen was resolved on 14Jul2021, while that of had a little nausea was not resolved at the time of this report. The clinical outcome of the events the rash began to itch and more bumps formed around her navel, appetite was gone and her tongue feeling funny, felt fatigued all day, left side (of her waist) and back had started itching was not resolved at the time of this report.

Other Meds: FISH OIL; VITAMIN C [ASCORBIC ACID]

Current Illness:

ID: 1653262
Sex: M
Age:
State: UT

Vax Date: 05/18/2021
Onset Date: 05/18/2021
Rec V Date: 08/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Migraines; Persistent cough; Aches/pain for 48 hours following administration; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0188) via an unspecified route of administration on 18May2021 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included finasteride (PROPECIA) for unknown indication started on an unknown date. The patient previously took amoxicillin (MANUFACTURER UNKNOWN) on an unknown date and experienced allergy. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration on 27Apr2021 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18May2021, the patient experienced aches/pain for 48 hours following administration. On 28May2021, the patient experienced migraines, persistent cough lasting 6 weeks post administration. Therapeutic measures were taken as a result of cough and included treatment with cough suppressant. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event aches/pain was recovered on an unknown date in 20May2021 after the duration of 48 hours and the events migraines and persistent cough was not recovered at the time of this report.

Other Meds: PROPECIA

Current Illness:

ID: 1653263
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/29/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: feeling an ache at that location/then got second dose and once again 10 days later got the sharp pain; This is a spontaneous report from a contactable consumer or other non-hcp (patient himself). A 61-years-old male patient received bnt162b2 (BNT162B2, Formulation: Solution for injection, Lot number was not reported, Expiry date: Unknown) via an unspecified route of administration in Arm Left on an unspecified date as dose 1, single and via an unspecified route of administration in Arm Left on an unspecified date (Lot number and Expiry date was not reported) as dose 2, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced feeling an ache at that location/then got second dose and once again 10 days later got the sharp pain on an unspecified date. This had been going on 2 maybe 3 months now. When the pain happens, it does not last long but was noticeable. He states he has a Dr appointment in Sep or Oct and he will call back again right before that to see if there was any updated information about this adverse event lasting this long and then he might ask the Dr to do testing on it. He will also start keeping a log about when this happens. The outcome of the event was unknown. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1653264
Sex: F
Age:
State: FL

Vax Date: 06/29/2021
Onset Date: 06/30/2021
Rec V Date: 08/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210630; Test Name: d dimer; Result Unstructured Data: Test Result:elevation; Test Date: 20210630; Test Name: heart rate; Result Unstructured Data: Test Result:High

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Chest pain; High heart rate; positive d dimer elevation; This is a spontaneous report from a contactable consumer or other non hcp. A 28-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 29Jun2021 17:30 (Age at vaccination 28 years old) (Batch/Lot Number: Ewo180) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included drug hypersensitivity from an unknown date and unknown if ongoing known allergies: Penicillin. The patient's concomitant medications were not reported. on 30Jun2021 21:00 the patient experienced chest pain High heart rate, positive d dimer elevation.The patient underwent lab tests and procedures which included fibrin d dimer: elevation on 30Jun2021, heart rate: high on 30Jun2021. Outcome of the events was not recovered. Follow-up (30Jul2021 & 05Aug2021): This is a follow-up spontaneous report from a contactable consumer. This consumer reported in response to HCP letter sent via telephonic follow-up activity that includes Follow-up attempts are completed. No further information is expected

Other Meds:

Current Illness:

ID: 1653265
Sex: F
Age:
State: IL

Vax Date: 05/18/2021
Onset Date: 06/29/2021
Rec V Date: 08/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Random muscle twitching in arms, legs, fingers and toes; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration on 18May2021 at 14:00 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history reported. The patient had no known allergies reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in right arm on 27Apr2021 at 14:00 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. On 29Jun2021, the patient experienced random muscle twitching in arms, legs, fingers and toes. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The event did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the event random muscle twitching in arms, legs, fingers and toes was not recovered at the time of this report.

Other Meds:

Current Illness:

ID: 1653266
Sex: M
Age:
State: AZ

Vax Date: 03/06/2021
Onset Date: 03/01/2021
Rec V Date: 08/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Developed a salty taste in mouth; This is a spontaneous report from a contactable consumer, the patient. A 73-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the left arm on 06Mar2021 at 13:00 (at the age of 73-years-old) as a single dose and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 28Mar2021 at 13:00 (at the age of 73-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension (controlled). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included hydrochlorothiazide; lisinopril (LISINOPRIL-HCTZ), acetylsalicylic acid (BABY ASPIRIN) and multi vitamin (unspecified); all from unknown dates for unknown indications and unknown if ongoing. The patient previously received olmesartan medoxomil (BENICAR) and experienced drug allergy. On an unknown date in Mar2021, shortly after receiving the first dosage of vaccine, the patient developed a salty taste in the mouth. The patient contacted his primary care physician (PCP) and was suggested to increase the water intake, which the patient did but had no effect. The problem only got worse and now the patient tasted almost nothing but salt. The event resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the event which included treatment with increased water intake. The clinical outcome of the event developed a salty taste in the mouth was not recovered at the time of this report.

Other Meds: LISINOPRIL/HCTZ; BABY ASPIRIN

Current Illness:

ID: 1653267
Sex: F
Age:
State: OH

Vax Date: 05/12/2021
Onset Date: 05/12/2021
Rec V Date: 08/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: shoulder pain; Neck pain; vertigo; fatigue; muscle weakness; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 12May2021 at 09:00 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient previously took montelukast sodium(SINGULAIR) on an unknown date for unknown indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included levocetirizine dihydrochloride (XYZAL), fluticasone propionate (FLONASE) and nortriptyline hydrochloride (NORTRIPTYLINE); all on an unknown date for unknown indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12May2021 at 10:00 the patient experienced Neck and shoulder pain, vertigo, fatigue, muscle weakness. The event resulted in doctor or other healthcare professional office/clinic visit. The events resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event Neck and shoulder pain, vertigo, fatigue, muscle weakness was not resolved at the time of this report. The lot number for BNT162b2 was not provided and will be requested during follow up

Other Meds: XYZAL; FLONASE [FLUTICASONE PROPIONATE]; NORTRIPTYLINE

Current Illness:

ID: 1653268
Sex: M
Age:
State: PA

Vax Date: 03/17/2021
Onset Date: 03/18/2021
Rec V Date: 08/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Brain fog; Mental fatigue; Lack of concentration; Mild tremors in hands; Anxiety; Depression; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 17Mar2021 at 13:00 (at the age of 31-years-old) and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 07Apr2021 at 13:00 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included autoimmune symptoms which subsided before vaccination. The patient was not allergic to medications, food, or other products. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Mar2021, the patient experienced brain fog, mental fatigue, lack of concentration, mild tremors in hands, anxiety and depression. The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department visit or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events brain fog, mental fatigue, lack of concentration, mild tremors in hands, anxiety and depression were not resolved at the time of report.

Other Meds:

Current Illness:

ID: 1653269
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: developed post-menopausal bleeding.; developed unilateral tremors in her forearms when reaching out, and also in her knees when walking downstairs; This is a spontaneous report from a non-contactable consumer (patient). A 57-year-old female patient received BNT162B2 (PFIZER BIONTECH COVID-19 VACCINE, solution for injection) via an unspecified route of administration, administered in Arm Left on 20Apr2021 Lot number was not reported) as dose number unknown, single and on an unspecified date via an unspecified route of administration as dose number unknown, single; for COVID-19 immunisation. The patient's medical history was not reported. No COVID prior vaccination. The patient was not pregnant at the time of vaccination. There were no concomitant medications. No other vaccine was given in four weeks. No other medications in two weeks. The patient previously took fluoroquinolones and clarithromycin (BIAXIN) and experienced allergies. After being fully vaccinated, patient developed unilateral tremors in her forearms when reaching out, and also in her knees when walking downstairs. She also developed postmenopausal bleeding. These seem to be staying with the patient. No treatment was given for the events. Patient has not done a COVID tested post vaccination. The events resulted in doctor or other healthcare professional office/clinic visit. The outcome of the events was not recovered. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1653270
Sex: F
Age:
State: NY

Vax Date: 07/09/2021
Onset Date: 07/11/2021
Rec V Date: 08/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Neck pain; This is a spontaneous report from a contactable consumer, the patient. A 69-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0198) via an unspecified route of administration in the left arm on 09Jul2021 at 11:00 (at the age of 69-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Concomitant medications included paracetamol (TYLENOL) and calcium/vitamin D 600 (MANUFACTURER UNKNOWN); both for unknown indication, from unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 11Jul2021 at 10:00, the patient experienced neck pain. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event neck pain was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: TYLENOL; CALCIUM;VITAMIN D NOS

Current Illness:

ID: 1653271
Sex: F
Age:
State: FL

Vax Date: 07/02/2021
Onset Date: 07/02/2021
Rec V Date: 08/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: Fever; Result Unstructured Data: Test Result:102 Severe; Test Date: 20210712; Test Name: Fever; Result Unstructured Data: Test Result:101.3

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Sore throat; headache; Joints on fire; bones/mucles on fire; Extremely fatigued; More than just moderately ill; feeling bad; Fever; Severe lymphadenopathy under arms (huge), neck & groin; Stiff neck; Stiff jaw; Very swollen tongue; trouble swallowing; Painful tongue; This is a spontaneous report from a contactable consumer (patient). A 56-year-old non-pregnant female patient (not pregnant at the time of vaccination) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EW0181), via an unspecified route of administration in left arm on 02Jul2021 at 11:00 AM (at the age of 56 years old) as single dose for covid-19 immunisation. Medical history included gastrooesophageal reflux disease, anxiety, depression, insomnia, attention deficit hyperactivity disorder from an unknown date and unknown if ongoing. The patient did not have any known allergies. Concomitant medications in two weeks included trazodone; fluoxetine hydrochloride (PROZAC); esomeprazole sodium (NEXIUM [ESOMEPRAZOLE SODIUM]); hydroxyzine for an unspecified indication, start and stop date were not reported. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EW0202), via an unspecified route of administration in left arm at 11:00 AM for covid-19 immunisation. The patient did not receive any other vaccines within 4 weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient hasn't been tested for COVID-19. On 02Jul2021 at 19:00 patient experienced fever up to 102, severe lymphadenopathy under arms (huge), neck and groin, stiff neck jaw, very swollen/painful tongue, trouble swallowing, sore throat, headache, joints/bones/mucles on fire, extremely fatigued. More than just moderately ill 02Jul2021-08Jul2021. Then felt fully recovered and great! for 3 days 09Ju2021l-11Jul2021. On 12Jul2021 symptoms hit her again. Fever 101.3, lymph nodes under arms and neck swollen/tender, stiff neck, headache, sore throat, trouble swallowing, joints/bones on fire. Completely fatigued and feeling bad. It's been 12 days since her 2nd Pfizer vaccination. She doesn't know what to expect, recovering and feeling great! 110% from 09Jul2021-11Jul2021 only to be knocked out again (literally came out of nowhere). There's no way to update her info that she was again very symptomatic. Report doesn't appear to have that ability. There's no info for those who don't recover in the expected 2-3 days. Those not sick enough for the hospital but are in bed at home unable to work. The patient has appointment with my PCP tomorrow. The events resulted in doctor or other healthcare professional office/clinic visit. The patient underwent lab tests and procedures which included body temperature: 102 severe, body temperature: 101.3 on 12Jul2021. Therapeutic measures were taken as a result of fever, severe lymphadenopathy under arms(huge), neck and groin, stiff neck, stiff jaw, very swollen tongue, painful tongue, trouble swallowing, sore throat, headache, joints on fire, bones/mucles on fire, extremely fatigued, more than just moderately ill, feeling bad. The outcome of events was not recovered. Follow-Up (30Jul2021): Follow-up attempts are completed. No further information is expected.

Other Meds: TRAZODONE; PROZAC; NEXIUM [ESOMEPRAZOLE SODIUM]; HYDROXYZINE

Current Illness:

ID: 1653272
Sex: F
Age:
State: NC

Vax Date: 03/18/2021
Onset Date: 03/18/2021
Rec V Date: 08/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 202009; Test Name: CT scan; Result Unstructured Data: Test Result:Nothing Abnormal; Test Date: 20210318; Test Name: Heart Rate; Result Unstructured Data: Test Result:Fast; Test Date: 202010; Test Name: COVID-19; Test Result: Negative ; Test Date: 20210318; Test Name: Weight; Result Unstructured Data: Test Result:loss

Allergies:

Symptom List: Vomiting

Symptoms: Nausea; vomiting; Dizziness; Intense menstrual cramps/bleeding; Intense menstrual cramps/bleeding; swollen lymph nodes; Ear infection; loss of appetite; weight loss; fast heart rate; This is a spontaneous report from a contactable consumer reported for herself. A 21-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot Number: EP6935; Expiration date was not reported), intramuscular, administered in Arm Left on 18Mar2021 15:00 (at the age of 21-years-old) as DOSE 1, SINGLE for covid-19 immunisation at Pharmacy or Drug Store. Patient was not pregnant at the time of vaccination. Medical history included vertigo and ear pain (no surgeries unexplained occurrence) from 08Jan2020 and ongoing. Patient had no known allergies and other medical history. Family medical history relevant to AE included none. There were no concomitant medications. Other vaccines within 4 weeks prior to the COVID vaccine include none. The patient experienced nausea, vomiting, dizziness, intense menstrual cramps/bleeding, swollen lymph nodes, ear infection, loss of appetite, weight loss, fast heart rate on 18Mar2021. The patient underwent lab tests and procedures which included CT scan: nothing abnormal on Sep2020, heart rate: fast on 18Mar2021, sars-cov-2 test (COVID-19 test): negative on Oct2020, weight: loss on 18Mar2021. Therapeutic measures were taken as a result of ear infection which included antibiotics. AE resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/ department or urgent care. The events were not serious and seriousness criteria included none. Patient had nausea and vomiting for 3 days following vaccine, dizziness, intense menstrual cramps/ bleeding ever since vaccine, swollen lymph nodes for 3 months following vaccine, ear infection for 2 months immediately following vaccine, loss of appetite and weight loss, fast heart rate ever since vaccine received. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Clinical outcome of nausea, vomiting was recovered on 21Mar2021, ear infection recovered on unspecified date in May2021, swollen lymph nodes recovered on unspecified date in Jun2021, and outcome of other events was unknown. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness: Ear pain (No surgeries unexplained occurence); Vertigo (No surgeries unexplained occurence)

ID: 1653273
Sex: F
Age:
State: CA

Vax Date: 06/26/2021
Onset Date: 06/26/2021
Rec V Date: 08/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Headache; Chills; Fever; Back pain; Fatigue; Sore arm; This is a spontaneous report from a non-contactable consumer, the patient. A 37-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0196) via an unspecified route of administration in the left arm on 26Jun2021 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. The patients' medical history included COVID-19 and back surgery on an unknown date in 2013. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications included birth control (unspecified), multi-vitamin (unspecified), probiotic (unspecified) and calcium (MANUFACTURER UNKNOWN); all for unknown indications from unknown dates and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Jun2021, the patient experienced headache, chills, fever, back pain, fatigue and sore arm. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, chills, fever, back pain, fatigue and sore arm was resolved on an unknown date in 2021 at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: CALCIUM

Current Illness:

ID: 1653274
Sex: F
Age:
State:

Vax Date: 07/02/2021
Onset Date: 07/03/2021
Rec V Date: 08/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Body aches; Fever; Joint pain; This is a spontaneous report from a non-contactable consumer, the patient. A 52-year-old female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration on 02Jul2021 at 17:30 (at the age of 52-years-old) as single dose for COVID-19 immunisation. Medical history included COVID-19 and artificial heart valve. The patient had known allergies to sulpha. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Jul2021 at 11:00, the patient experienced body aches, fever and joint pain. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events body aches, fever and joint pain was unknown at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1653275
Sex: F
Age:
State: MA

Vax Date: 04/24/2021
Onset Date: 04/24/2021
Rec V Date: 08/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: She could not raise her left arm until now and she had piercing pain when she moved it. It was difficult even to dress up. The piercing pain woke her up at night a lot of times; she could not move her left arm upward/ She could not tie her hair and became so difficult to remove her clothes or put them on; but her arms did not recover from pain; This is a spontaneous report from a contactable consumer reported for herself. A 60-year-old female patient (not pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via intramuscular, administered in Arm Left on 24Apr2021 (Lot Number: EW0170) at age of 60-year-old as single dose for covid-19 immunisation. The patient received 1st dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) administered in Arm Left on 02Apr2021 15:45 at age of 60-year-old (Lot Number: ER8732), for covid-19 immunisation, after the first dose, she was fine after 3 days of flu like symptoms. Medical history included Type II diabetes, onset date: 8 or more year ago (she was fine with blood glucose, she was on low carb keto diet) and known allergies: aspirin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not have COVID tested post vaccination and did not have COVID prior vaccination. Concomitant medications included metformin (METFORMIN); glimepiride (GLIMEPIRIDE). It was reported on 24Apr2021 21:00, After the second dose, she was waiting to recover from it but her arms did not recover from pain, she could not move her left arm upward and it was now painful to raise her left arm or reach her back. She could not raise her left arm until now and she had piercing pain when she moved it. It was difficult even to dress up. The piercing pain woke her up at night a lot of times. She could not tie her hair and became so difficult to remove her clothes or put them on. She could not lean on it when she was sleeping and it woke her up when she accidently turn to the left. It was uncomfortable even if she was not leaning on it that she needed extra pillow under it. Seriousness criteria was reported as persistence/ significant disability incapability. The events required visiting to physician office. The patient had seen her doctor. No treatment was received for the events. The outcome of events was not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds: METFORMIN; GLIMEPIRIDE

Current Illness:

ID: 1653276
Sex: F
Age:
State: TX

Vax Date: 03/07/2021
Onset Date: 04/30/2021
Rec V Date: 08/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Lost her eyebrows hair; Hair started falling out.; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 07Mar2021(at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Patient received unspecified blood pressure medications within 2 weeks of vaccination. Patient had no known allergies to food, medication or other products. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on an unknown date in 2021 as a single dose for COVID-19 immunisation. On 30Apr2021, the patient stated that she lost her eyebrows hair, looks as if she had cancer by eyes and also experienced hair started falling out. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event she lost her eyebrows hair, looks as if she had cancer by eyes and also experienced hair started falling out was not recovered at the time of this report.

Other Meds:

Current Illness:

ID: 1653277
Sex: M
Age:
State: GA

Vax Date: 07/05/2021
Onset Date: 07/06/2021
Rec V Date: 08/29/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Fever; Headache; Nausea; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 12-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 05Jul2021 at 18:00 (at the age of 12-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 from an unknown date. The patient had no known allergies reported. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any other medications within two weeks of the COVID vaccine. On 06Jul2021 at 08:00, the patient experienced fever, headache, nausea and fatigue that lasted for 3 days. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events fever, headache, nausea and fatigue were resolved on 09Jul2021. The lot number for BNT162b2 was not provided and will be requested during follow up.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am